LowDE, PichicheroME, SchaadUB. Optimizing antibacterial therapy for community-acquired respiratory tract infections in children in an era of bacterial resistance. Clin Pediatr (Phila)2004;43(2):135–51.
2.
KleinJO. Strategies for decreasing multidrug antibiotic resistance: Role of ototopical agents for treatment of middle ear infections. Am J Manag Care2002;8(14 Suppl):S345–52.
3.
DaganR.Treatment of acute otitis media—challenges in the era of antibiotic resistance. Vaccine2000;19(suppl 1):S9–S16.
4.
Ford-JonesEL, FriebergJ, McGeerA, Microbiologic findings and risk factors for antimicrobial resistance at myringotomy for tympanostomy tube placement—a prospective study of 601 children in Toronto. Int J Pediatr Otorhinolaryngol2002;66(3):227–42.
5.
DarrowDH, DashN, DerkayCS. Otitis media: Concepts and controversies. Curr Opin Otolaryngol Head Neck Surg2003;11(6):416–23.
6.
GehannoP, PanajotopoulosA, BarryB, Microbiology of otitis media in the Paris, France, area from 1987 to 1997. Pediatr Infect Dis J2001;20(6):570–3.
7.
DaganR, HobermanA, JohnsonC, Bacteriology and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J2001;20(9):829–37.
8.
KilpiT, HervaE, KaijalainenT, Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J2001;20(7):654–62.
9.
LeskinenK, HendolinP, Virolainen-JulkunenA, Alloiococcus otitidis in acute otitis media. Int J Pediatr Otorhinolaryngol2004;68(1):51–6.
10.
HimiT, KitaH, MitsuzawaA, Effect of Alloiococcus otitidis and three pathogens of otitis media in production of interleukin-12 by human monocyte cell line. FEMS Immunol Med Microbiol2000:29(2):101–16.
11.
VijayasekaranS, ThorntonR, ProsserK, Alloiococcus otitidis in otitis media. Presented at the annual meeting of the American Society of Pediatric Otolaryngology; April 29, 2007; San Diego.
12.
American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics2004;113(5):1451–65.
13.
BrookI, GoberEA. Antimicrobial resistance in the nasopharyngeal flora of children with acute otitis media and otitis media recurring after amoxicillin therapy. J Med Microbiol2005;54(Pt 1):83–5.
14.
PichicheroME. Recurrent and persistent otitis media. Pediatr Infect Dis J2000;19(9):911–16.
15.
HuebnerRE, WasasAD, HockmanM, Bacterial aetiology of non-resolving otitis media in South African children. J Laryngol Otol2003;117(3):169–72.
16.
RolandPS, StromanDW. Microbiology of acute otitis externa. Laryngoscope2002;112(7 Pt 1):1166–77.
17.
KleinJO. In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents. Pediatr Infect Dis J2001;20(1):102–3; discussion 120–2.
18.
CouzosS, LeaT, MuellerR, Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children. A community-based, multicentre, double-blind randomised controlled trial. Med J Aust2003;179(4):185–90.
19.
CantrellHF, LombardyEE, DuncansonFP, Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials. South Med J2004;97(5):465–71.
20.
MandelEM, CasselbrantML, Kurs-LaskyM.Acute otorrhea: Bacteriology of a common complication of tympanostomy tubes. Ann Otol Rhinol Laryngol1994;103(9):713–18.
21.
CoticchiaJM, DoharJE. Methicillin-resistant Staphylococcus aureus otorrhea after tympanostomy tube placement. Arch Otolaryngol Head Neck Surg2005;131(10):868–73.
22.
WeberPC, RolandPS, HannleyM, The development of antibiotic resistant organisms with the use of ototopical medications. Otolaryngol Head Neck Surg2004;130(3 Suppl):S89–94.
JangCH, ParkSY. Emergence of ciprofloxacin-resistant Pseudomonas in chronic suppurative otitis media. Clin Otolaryngol Allied Sci2004;29(4):321–3.
25.
EspositoS, D'ErricoG, MontanaroC.Topical and oral treatment of chronic otitis media with ciprofloxacin. A preliminary study. Arch Otolaryngol Head Neck Surg1990;116(5):557–9.
26.
EspositoS, NovielloS, D'ErricoG, MontanaroC.Topical ciprofloxacin vs intramuscular gentamicin for chronic otitis media. Arch Otolaryngol Head Neck Surg1992;118(8):842–4.
27.
YuenPW, LauSK, ChauPY, Ofloxacin eardrop treatment for active chronic suppurative otitis media: Prospective randomized study. Am J Otol1994;15(5):670–3.
28.
FradisM, BrodskyA, Ben-DavidJ, Chronic otitis media treated topically with ciprofloxacin or tobramycin. Arch Otolaryngol Head Neck Surg1997;123(10):1057–60.
CoatesH.Chronic suppurative otitis media without cholesteatoma. In: AlperCM, BluestoneCD. eds. Advanced Therapy of Otitis Media. Hamilton, Ont.; London: B.C. Decker; 2004:299–305.
31.
FiremanB, BlackSB, ShinefieldHR, Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J2003;22(1):10–16.
32.
PichicheroME. Pathogen shifts and changing cure rates for otitis media and tonsillopharyngitis. Clin Pediatr (Phila)2006;45(6):493–502.
33.
ClementsDA, LangdonL, BlandC, WalterE.Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med1995;149(10):1113–17.
34.
BelsheRB, MendelmanPM, TreanorJ, The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med1998;338(20):1405–12.